Lameness in Right Forelimb

12 Year old Mixed Breed Gelding:

Pluto was a 12-year-old mixed breed gelding that had been used for Hunting for over six years and developed progressive unevenness in the contact and reluctance to exercise over six months.

Examination:

A physical examination found the horse to be 3/5 lame in the right forelimb, with diagnostic analgesia isolating the source of lameness to the distal interphalangeal (coffin) joint. Upon needle placement into the joint copious, pale, low viscosity fluid poured out of the needle, indicating active inflammation within the joint. Radiographs identified osteoarthritic changes within the coffin joint. Namely sharp spur development of the short pastern and pedal bone (as indicated by the green arrows, image left) and irregular, lucent modelling of the dorsal aspect of the short pastern bone at the attachment site of the joint capsule (indicated by the blue arrow). In addition to this, there was significant foot imbalance, which was corrected first. After four weeks, the degree of poor performance was reduced but not abolished.

Treatment and Outcome: 

2ml of Arthramid Vet was injected into the right fore coffin joint. The horse was then rested for 48 hours before commencing an ascending exercise program over two weeks to return to a full exercise regime. Over the space of four weeks, the clinical signs dissipated with the horse willingly and comfortably able to train and hunt. The joint was medicated 16 months previously, and there has not been a recurrence of clinical signs since that time.

 

Arthramid Vet 2.5% PAAG

Precision Medicine

  • Studies show up to 82.5% of horses respond with a successful resolution of joint lameness.
  • Meets Animal Welfare Concerns; Arthramid Vet is not simply a lubricant or painkiller. Its unique biomedical technology that helps heal and restore the joint to healthy function.
  • Made to Last; When compared to traditional treatments for joint lameness, research shows that Arthramid Vet is better and lasts longer with proven efficacy for up to 1- 2 years.
  • One of A Kind; Arthramid Vet's unique and patented IL-X Cross-Linking technology makes it the safest and most effective 2.5% Polyacrylamide (PAAG) Hydrogel available.
  • Addresses Equine Welfare Concerns
  • Long-lasting Clinical Effects of Treatment
  • 82.5% Successful Resolution of Joint Lameness

Get In Touch

Contact Us

First Name:
Last Name:
Your Email:
Phone:
Business Name:
Subject:

IMS Vet
Phone +64 (09) 8013 253
sales@imsvet.com

Arthramid Vet Australia

Registered in Australia to: IMS Vet Pty Limited, 1953 Grampian's Road, Fyans Creek, Victoria 3381. Registered pursuant to the APVMA Number 86728/0320. See www.apvma.gov.au for registration conditions.

Address for Service:
IMSVet, PO Box 1083, Cambridge 3450, New Zealand
Phone +61 (0272) 018 497
sales@imsvet.com